A report published in the Cochrane Library stated that although ARBs are somewhat better tolerated compared to ACE inhibitors, the availability of higher quality information and statistics backing up the utilization of ACE inhibitors, which can prevent mortality, strokes, and heart disease, are needed to be considered before selecting ARBs over ACE inhibitors [7]. The gene discussed is ACE; the disease is stroke disorder.